Molecular docking, dynamics, and pharmacology studies on bexarotene as an agonist of ligand-activated transcription factors, retinoid X receptors
Version 2 2024-06-04, 15:55Version 2 2024-06-04, 15:55
Version 1 2021-09-28, 13:18Version 1 2021-09-28, 13:18
journal contribution
posted on 2024-06-04, 15:55 authored by N Chitranshi, Y Dheer, S Kumar, SL Graham, V GuptaMolecular docking, dynamics, and pharmacology studies on bexarotene as an agonist of ligand-activated transcription factors, retinoid X receptors
History
Journal
Journal of Cellular BiochemistryVolume
120Pagination
11745-11760Location
Chichester, Eng.ISSN
0730-2312eISSN
1097-4644Language
engPublication classification
C1 Refereed article in a scholarly journalIssue
7Publisher
WileyUsage metrics
Categories
Keywords
7,8-DIHYDROXYFLAVONEACIDALPHAbexaroteneBINDING DOMAINBiochemistry & Molecular BiologyCell BiologyCELLSCRYSTAL-STRUCTUREdockingFLEXIBILITYHETERODIMERIZATIONLife Sciences & Biomedicinemolecular dynamicsPROTEINretinoic acidretinoid X receptorsScience & TechnologySIMULATIONS3209 Neurosciences3214 Pharmacology and pharmaceutical sciences
Licence
Exports
RefWorksRefWorks
BibTeXBibTeX
Ref. managerRef. manager
EndnoteEndnote
DataCiteDataCite
NLMNLM
DCDC